Shares of Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $3.87, but opened at $3.59. Raia Drogasil shares last traded at $3.59, with a volume of 313 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold”.
Read Our Latest Research Report on Raia Drogasil
Raia Drogasil Price Performance
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Recommended Stories
- Five stocks we like better than Raia Drogasil
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
